Christian Rolfo, a professor of medicine at the Icahn School of Medicine at Mount Sinai, and his team utilized PD-L1 in EVs extracted from blood to better predict and dynamically evaluate the response of non-small cell lung cancer(NSCLC) patients to cancer immunotherapy (75). Here, CD274 is linked to non-small cell lung carcinoma.